BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25344883)

  • 1. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and functional status after resection of recurrent glioblastoma multiforme.
    Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
    Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct volume after glioblastoma surgery as an independent prognostic factor.
    Bette S; Wiestler B; Kaesmacher J; Huber T; Gerhardt J; Barz M; Delbridge C; Ryang YM; Ringel F; Zimmer C; Meyer B; Boeckh-Behrens T; Kirschke JS; Gempt J
    Oncotarget; 2016 Sep; 7(38):61945-61954. PubMed ID: 27566556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of glioblastoma in the elderly: the impact of complications.
    Karsy M; Yoon N; Boettcher L; Jensen R; Shah L; MacDonald J; Menacho ST
    J Neurooncol; 2018 May; 138(1):123-132. PubMed ID: 29392589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma.
    Bir SC; Connor DE; Ambekar S; Wilden JA; Nanda A
    Neurosurg Rev; 2015 Oct; 38(4):705-13. PubMed ID: 25864406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
    Cheng X; Lou S; Huang S; Chen H; Liu J
    World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
    Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1131-7. PubMed ID: 25577223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.
    Chaichana KL; Chaichana KK; Olivi A; Weingart JD; Bennett R; Brem H; Quiñones-Hinojosa A
    J Neurosurg; 2011 Mar; 114(3):587-94. PubMed ID: 20887095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.
    Uzuka T; Aoki H; Natsumeda M; Takahashi H; Fujii Y
    Neurol Med Chir (Tokyo); 2012; 52(8):570-6. PubMed ID: 22976140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors influencing clinical outcomes of glioblastoma multiforme.
    Li SW; Qiu XG; Chen BS; Zhang W; Ren H; Wang ZC; Jiang T
    Chin Med J (Engl); 2009 Jun; 122(11):1245-9. PubMed ID: 19567131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.